Benzinga | Nov 9, 2021 05:50PM EST

OptimizeRx Q3 EPS $0.09 Misses $0.13 Estimate, Sales $16.13M Beat $15.06M Estimate

OptimizeRx (NASDAQ:OPRX) reported quarterly earnings of $0.09 per share which missed the analyst consensus estimate of $0.13 by 30.77 percent. This is a 28.57 percent increase over earnings of $0.07 per share from the same period last year. The company reported quarterly sales of $16.13 million which beat the analyst consensus estimate of $15.06 million by 7.07 percent. This is a 53.29 percent increase over sales of $10.52 million the same period last year.